Literature DB >> 21120363

Use of heterologous antigens for the immunodiagnosis of abdominal angiostrongyliasis by an enzyme-linked immunosorbent assay.

Renata Ben1, Rubens Rodrigues, Aventino Alfredo Agostini, Carlos Graeff-Teixeira.   

Abstract

Angiostrongylus costaricensis has a broad geographic distribution spanning from North to South America and the infections of vertebrates with this nematode can result in abdominal complications. Human infections are diagnosed by histological or serological methods because the isolation of larvae from feces is not feasible, as most parasites become trapped in intestinal tissues due to intense eosinophilic inflammation. Because A. costaricensis is difficult to maintain in the laboratory, an immunodiagnostic IgG enzyme-linked immunosorbent assay (ELISA) using antigens from the congeneric Angiostrongylus cantonensis species was evaluated against a panel of serum samples from patients who were histologically diagnosed with A. costaricensis infections. Sera from uninfected individuals and individuals infected with other parasites were used as controls. The sensitivity and specificity of the assay were estimated at 88.4% and 78.7%, respectively. Because the use of purified or cloned antigens has not been established as a reliable diagnostic tool, the use of heterologous antigens may provide a viable alternative for the development of an ELISA-based immunodetection system for the diagnosis of abdominal angiostrongyliasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21120363     DOI: 10.1590/s0074-02762010000700013

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  7 in total

1.  Expression of recombinant antigenic proteins from Angiostrongylus cantonensis: a brief report.

Authors:  Alessandra L Morassutti; Andrey Perelygin; Keith Levert; Seh-Ching Lin; Yeuk-Mui Lee; Alexandre J da Silva; Patricia P Wilkins; Carlos Graeff-Teixeira
Journal:  Hawaii J Med Public Health       Date:  2013-06

2.  The 31-kDa antigen of Angiostrongylus cantonensis comprises distinct antigenic glycoproteins.

Authors:  Alessandra L Morassutti; Keith Levert; Andrey Perelygin; Alexandre J da Silva; Patricia Wilkins; Carlos Graeff-Teixeira
Journal:  Vector Borne Zoonotic Dis       Date:  2012-08-27       Impact factor: 2.133

3.  Development-specific differences in the proteomics of Angiostrongylus cantonensis.

Authors:  Hui-Cong Huang; Li-Li Yao; Zeng-Mei Song; Xing-Pan Li; Qian-Qian Hua; Qiang Li; Chang-Wang Pan; Chao-Ming Xia
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

4.  Immunoanalysis of different antigenic preparations of Angiostrongylus cantonensis for neuroangiostrongyliasis diagnosis improvement.

Authors:  Leyva Cecília Vieira de Melo; Felipe Corrêa Rezende de Souza; Amanda de Oliveira Baccin; Dan Jessé Gonçalves da Mota; Vera Lucia Pereira-Chioccola; Pedro Luiz Silva Pinto
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-10-03       Impact factor: 2.747

Review 5.  Abdominal angiostrongyliasis in the Americas: fifty years since the discovery of a new metastrongylid species, Angiostrongylus costaricensis.

Authors:  Alicia Rojas; Arnaldo Maldonado-Junior; Javier Mora; Alessandra Morassutti; Rubens Rodriguez; Alberto Solano-Barquero; Anamariela Tijerino; Marianela Vargas; Carlos Graeff-Teixeira
Journal:  Parasit Vectors       Date:  2021-07-22       Impact factor: 3.876

6.  A protein microarray for the rapid screening of patients suspected of infection with various food-borne helminthiases.

Authors:  Jia-Xu Chen; Mu-Xin Chen; Lin Ai; Jun-Hu Chen; Shao-Hong Chen; Yong-Nian Zhang; Yu-Chun Cai; Xing-Quan Zhu; Xiao-Nong Zhou
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

7.  Angiostrongylus costaricensis infection in Martinique, Lesser Antilles, from 2000 to 2017.

Authors:  Céline Dard; Duc Nguyen; Charline Miossec; Katia de Meuron; Dorothée Harrois; Loïc Epelboin; André Cabié; Nicole Desbois-Nogard
Journal:  Parasite       Date:  2018-04-10       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.